GlassScriptPhysician profile
Vinamra Kumar Jain
NPI 1427388925
$4,224.73
in general payments reported to CMS, 2019-2025
43 companies · $1,108 in 2025
The $1,108 reported for 2025 was more than what 88% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $307 · 2021: $514 · 2022: $159 · 2023: $746 · 2024: $1,241 · 2025: $1,108.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,095.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,095.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $812.93 | 2021-2025 | |
| Novo Nordisk INC | $446.63 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Acera Surgical, INC. | $260.29 | 2025 | Restrata Wound Matrix |
| Ets Wound Care LLC | $258.59 | 2024 | Mirragen Advanced Wound Matrix |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $253.17 | 2019-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $200.68 | 2023-2025 | Breztri, Airsupra, Farxiga |
| Lucid Diagnostics INC. | $180.54 | 2021 | |
| Boston Scientific Corporation | $177.43 | 2020-2025 | General - Therapies, General - Vascular Intervention |
| Smith+Nephew, INC. | $160.58 | 2023-2025 | Grafix Pl, Renasys Touch, Pico 7 |
| Musculoskeletal Transplant Foundation INC. | $143.22 | 2025 | |
| Edwards Lifesciences Corporation | $119.60 | 2020 | |
| Glaxosmithkline, LLC. | $100.43 | 2023-2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $92.44 | 2019-2024 | Spravato |
| Astellas Pharma US INC | $89.53 | 2024-2025 | Veozah |
| Takeda Pharmaceuticals U.S.A., INC. | $83.09 | 2020-2023 | Trintellix |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ekos Corporation | $66.61 | 2019 | |
| Surgenex LLC | $51.66 | 2025 | Surgraft, Ardeograft, Pellograft |
| Exact Sciences Corporation | $51.65 | 2023 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $49.12 | 2021-2023 | |
| Abbott Laboratories | $47.82 | 2022 | |
| Coopersurgical, INC. | $44.77 | 2022-2024 | Paragard T 380a |
| Allergan, INC. | $37.28 | 2020-2021 | |
| Organogenesis INC. | $36.85 | 2025 | Puraply Wound Matrix |
| Paratek Pharmaceuticals, INC. | $36.55 | 2025 | Nuzyra |
| Amgen INC. | $35.71 | 2023-2024 | Repatha, Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.29 | 2023-2025 | Jardiance |
| Nestle Healthcare Nutrition INC. | $32.93 | 2021-2022 | |
| Noven Therapeutics, LLC | $29.39 | 2025 | Xelstrym |
| Exeltis, USA INC. | $27.78 | 2020-2021 | |
| Medtronic, INC. | $24.20 | 2023 | Intellis Adaptivestim |
| Neuronetics, INC. | $23.96 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.89 | 2019 | |
| Advanced Oxygen Therapy INC. | $21.27 | 2023-2024 | Topical Oxygen Chamber For Extremities, Topical Oxygen Chamber For Extremities |
| Biowound Solutions, INC. | $21.11 | 2025 | Bio-Connekt |
| Organon LLC | $19.92 | 2021 | |
| Nevro Corp. | $19.07 | 2021 | |
| Aimmune Therapeutics, INC. | $18.89 | 2024 | |
| Pfizer INC. | $18.64 | 2025 | |
| Lilly USA, LLC | $16.65 | 2023 | Mounjaro |
| Itamar Medical INC | $16.06 | 2021-2024 | Watchpatone |
| Medtronic USA, INC. | $14.29 | 2020 | |
| Mimedx Group, INC. | $13.48 | 2025 | |
| Sonex Health, INC. | $12.74 | 2025 | Sx-One Microknife |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vinamra Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.